Amber Bokhari
Physician Assistant · Columbia, MDNPI 1255807228
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 318 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,978 and has fallen 59.1% since, to $1,217 in 2025. Among physician assistant clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 318 payments — averaging $23.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$627
- Teva Pharmaceuticals USA, Inc.$516
- Lundbeck LLC$497
- Bausch Health US, LLC$424
- plus $3K from 20 others
What the payments were for
- Food & beverage$7,36998%
- Education$1232%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $1,473 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 40 | $1,269 |
| Otsuka America Pharmaceutical, Inc. | 29 | $627 |
| Teva Pharmaceuticals USA, Inc. | 20 | $516 |
| Lundbeck LLC | 30 | $497 |
| Bausch Health US, LLC | 33 | $424 |
| E.r. Squibb & Sons, L.L.C. | 5 | $318 |
| Alkermes, Inc. | 10 | $269 |
| Axsome Therapeutics, Inc. | 5 | $266 |
| Neos Therapeutics, LP | 14 | $223 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $217 |
| Sunovion Pharmaceuticals Inc. | 9 | $194 |
| Supernus Pharmaceuticals, Inc. | 11 | $178 |
| Johnson & Johnson | 3 | $173 |
| Vanda Pharmaceuticals Inc. | 6 | $156 |
| Eisai Inc. | 10 | $149 |
| Neurocrine Biosciences, Inc. | 7 | $116 |
| Idorsia Pharmaceuticals US Inc | 1 | $110 |
| Noven Therapeutics, LLC | 4 | $76 |
| Adlon Therapeutics L.p. | 5 | $73 |
| Avanir Pharmaceuticals, Inc. | 3 | $47 |
| Almatica Pharma LLC | 2 | $38 |
| Merck | 2 | $28 |
| Ironshore Pharmaceuticals Inc. | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Corium, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$588
- CAPLYTA$555
- ARISTADA$440
- COBENFY$247
- Auvelity$215
- INVEGA SUSTENNA$139
- INVEGA TRINZA$139
- ARISTADA INITIO$110
- QUVIVIQ$110
- REXULTI$110
- ABILIFY MAINTENA$103
How this compares
$7,492 in reported general payments places this provider in the 95th percentile of 2,567 physician assistant providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 11 | $850 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 24 | $772 |
| Bupropion XlBupropion Hcl | 31 | $682 |
| Escitalopram Oxalate | 30 | $527 |
| Gabapentin | 31 | $291 |
| Hydroxyzine Hcl | 14 | $144 |
| Mirtazapine | 13 | $136 |
| Propranolol Hcl | 19 | $131 |
| Clonazepam | 26 | $106 |
| Alprazolam | 50 | $99 |
| Trazodone Hcl | 19 | $87 |
| Fluoxetine Hcl | 16 | $67 |
| Sertraline Hcl | 15 | $55 |
| Zolpidem Tartrate | 11 | $43 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $38 | $5515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,567 physician assistant providers in Maryland.
Other physician assistant in Columbia
- Mackenzie DoshiColumbia$14K
- Isabel RoseColumbia$13K
- Emily OhlandColumbia$11K
- Margaret JoyceTowson$220K
- Kara CossisBaltimore$177K
- Garland JamesSilver Spring$86K
- Melissa BearekmanBaltimore$81K
- Brittany YerkesSalisbury$81K
- Amy CollierTimonium$29K
- Hannah JohnsonNottingham$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.